Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Nomination Summary for Clarithromycin (N99022)

Nominated Substances: Clarithromycin

Nomination Date: 05/19/1999

Nominator: FDA

Rationale: Used in the treatment of mild to moderate infections caused by specific microorganisms. Hepatotoxicity, testicular atrophy, lymphoid depletion and renal tubular degeneration were observed in rats, dogs, and monkeys exposed to Clarithromycin. Lack of carcinogenicity data; current use patterns and rapid absorption and distribution into body tissues

NTP Principles: 2, 3, 7

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 81103-11-9

Agent Name: Clarithromycin